Ammonia toxicity: Comparative protective effect of various arginine and ornithine derivatives, aspartate, benzoate, and carbamyl glutamate

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Metabolic brain disease

• Publication date

  1986-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00998474PMID 3508233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ammonia metabolism, urea cycle capacity and their biochemical assessment.

  2009cited by this paper
• Is Intravenous Administration of Branched Chain Amino Acids Effective in the Treatment of Hepatic Encephalopathy? A Multicenter Study

  2007cited by this paper
• Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.

  1994cited by this paper
• Conditional deficiencies of ornithine or arginine.

  1986cited by this paper
• Advances in Hepatic Encephalopathy and Urea Cycle Diseases

  1984cited by this paper
• Urea cycle function in the dog with emphasis on the role of arginine.

  1984cited by this paper
• Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances.

  1984cited by this paper
• Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.

  1984cited by this paper
• A spectrin-like protein from mouse brain membranes: phosphorylation of the 235,000-dalton subunit.

  1984cited by this paper
• Mechanism of arginine protection against ammonia intoxication in the rat.

  1984cited by this paper
• Encephalopathic effect of phenol in rats.

  1983cited by this paper
• Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.

  1982cited by this paper
• Branched-chain amino acids vs lactulose in the treatment of hepatic coma

  1982cited by this paper
• The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy.

  1980cited by this paper
• Conditions affecting the colorimetry of orotic acid and orotidine in urine.

  1980cited by this paper
• Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.

  1977cited by this paper
• Letter: More sensitive mechanized determination of urea nitrogen.

  1975cited by this paper
• More Sensitive Mechanized Determination of Urea Nitrogen

  1975cited by this paper
• Urea‐Cycle Enzymes in Normal Liver and in Patients with Alcoholic Hepatitis

  1974cited by this paper
• Activities of Krebs-Henseleit enzymes in normal and cirrhotic human liver.

  1974cited by this paper
• Ammonia intoxication in rats: protection by N-carbamoyl-L-glutamate plus L-arginine.

  1972cited by this paper
• Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic l-amino acids: a preliminary report.

  1972cited by this paper
• THE EFFECT OF AMMONIA ADMINISTRATION ON OROTIC ACID EXCRETION IN RATS.

  1965cited by this paper
• Blood ammonia elevation and toxicity from intravenous L-amino acid administration to dogs: the protective role of L-arginine.

  1958cited by this paper
• Toxicity and blood ammonia rise resulting from intravenous amino acid administration in man: the protective effect of l-arginine.

  1957cited by this paper
• Effect of Intravenously Administered Amino Acids on Blood Ammonia.∗

  1956cited by this paper
• Studies on the metabolism of amino acids and related compounds in vivo. V. Effects of combined administration of nonprotective compounds and subprotective levels of L-arginine. HCI on ammonia toxicity in rats.

  1956cited by this paper
• Studies on the metabolism of amino acids and related compounds in vivo. I. Toxicity of essential amino acids, individually and in mixtures, and the protective effect of L-arginine.

  1956cited by this paper
• Studies on the metabolism of amino acids and related compounds in vivo. III. Prevention of ammonia toxicity by arginine and related compounds.

  1956cited by this paper

• An Open‐Label Randomized Controlled Non‐Inferiority Trial of Arginine Glutamate Injection for the Treatment of Mild Hepatic Encephalopathy

  2025cites this paper
• Changes of the liver metabolome following an intravenous lipopolysaccharide injection in Holstein cows supplemented with dietary carnitine

  2022cites this paper
• The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease

  2021cites this paper
• The Current Hepatic Encephalopathy Pipeline.

  2020cites this paper
• Roles of arginine in fish nutrition and health: insights for future researches

  2020cites this paper
• Effects of dietary arginine supplementation on ureagenesis and amino acid metabolism in common carp (Cyprinus carpio) exposed to ambient ammonia

  2019cites this paper
• Targeted metabolomic profiling in rat tissues reveals sex differences

  2018cites this paper
• Glutamine Synthetase: Role in Neurological Disorders.

  2016cites this paper
• Density functional theory (DFT) and natural bond orbital (NBO) study of vibrational spectra and intramolecular hydrogen bond interaction of L-ornithine-L-aspartate.

  2015cites this paper
• Ammonia‐Lowering Strategies for the Treatment of Hepatic Encephalopathy

  2012cites this paper
• Management of Hepatic Encephalopathy

  2011cites this paper
• Improving Survival in Patients with Decompensated Cirrhosis

  2011cites this paper
• Hepatic encephalopathy: the role of inflammation, ammonia andaquaporin expression in the pathogenesis of cerebral oedema

  2010cites this paper
• CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Efficacy of L-Ornithine L-Aspartate in Acute Liver Failure: A Double-Blind, Randomized, Placebo-Controlled Study

  2009cites this paper
• Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

  2009cites this paper
• Critical review of clinical trials of bone marrow stem cells in liver disease.

  2008cites this paper
• L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.

  2007cites this paper
• Amino Acid Challenge in Patients with Cirrhosis and Control Subjects: Ammonia, Plasma Amino Acid and EEG Changes

  2006cites this paper
• Management of hepatic encephalopathy

  2002cites this paper
• Suppression of ammonia-induced swelling by aspartate but not by ornithine in primary cultures of rat astrocytes.

  2002cites this paper
• Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels.

  1997cites this paper
• Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study

  1997cites this paper
• Ornithine aminotransferase as a therapeutic target in hyperammonemias.

  1997cites this paper
• Review article: pathogenesis and treatment of chronic hepatic encephalopathy.

  1996cites this paper
• [Hepatic encephalopathy. Physiopathology and treatment].

  1994cites this paper
• Protection against lethal ammonia intoxication: Synergism between endogenous ornithine and L-carnitine

  1994cites this paper
• Enhanced endogenous ornithine concentrations protect against tonic seizures and coma in acute ammonia intoxication.

  1993cites this paper
• On the mechanism of inhibition of gluconeogenesis and ureagenesis by sodium benzoate.

  1991cites this paper
• [Hepatic encephalopathy: its etiology, pathogenesis, clinical diagnostic criteria and treatment principles].

  1990cites this paper
• Ornithine aminotransferase activity, liver ornithine concentration and acute ammonia intoxication.

  1989cites this paper
• Studies of ammonia loading: Effects of rate of delivery and enhanced removal of NH4 on blood levels of ammonia and coma induction

  1989cites this paper
• Protection against acute hyperammonemia: the role of quaternary amines.

  1988cites this paper
• fficacy of L-Ornithine L-Aspartate in Acute Liver Failure : A Double-Blind , andomized , Placebo-Controlled Study

  year unknowncites this paper